We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+7.06%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$600M
AUM Growth
+$420M
Cap. Flow
+$429M
Cap. Flow %
71.56%
Top 10 Hldgs %
7.78%
Holding
1,485
New
912
Increased
233
Reduced
74
Closed
263

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.8%
2 Industrials 15.11%
3 Healthcare 13.87%
4 Technology 12.38%
5 Financials 11.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RDGT
1176
Ridgetech Inc
RDGT
$2.71M
$61K 0.01%
+2
New +$84.4K
QTNT
1177
DELISTED
Quotient Limited Ordinary Shares
QTNT
$61K 0.01%
+296
New +$76.7K
INDP icon
1178
Indaptus Therapeutics
INDP
$157M
$55K 0.01%
+97
New +$71.3K
TRST
1179
Trustco Bank Corp NY
TRST
$938M
$55K 0.01%
+2,117
New +$61.8K
GERN icon
1180
Geron
GERN
$949M
$54K 0.01%
+30,866
New +$57.1K
RUBY
1181
DELISTED
Rubius Therapeutics, Inc
RUBY
$54K 0.01%
+10,872
New +$57.6K
GMLP
1182
DELISTED
Golar LNG Partners LP
GMLP
$52K 0.01%
25,545
-427
-2% -$1.12K
ANH
1183
DELISTED
Anworth Mortgage Asset Corporation
ANH
$52K 0.01%
+31,542
New +$55.3K
ORMP icon
1184
Oramed Pharmaceuticals
ORMP
$179M
$51K 0.01%
+19,659
New +$68.5K
FARM
1185
DELISTED
Farmer Brothers
FARM
$50K 0.01%
+11,252
New +$66.7K
MUFG icon
1186
Mitsubishi UFJ Financial
MUFG
$254B
$50K 0.01%
+12,567
New +$50.7K
ORTX
1187
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$47K 0.01%
1,135
-936
-45% -$48.4K
NYMX
1188
DELISTED
Nymox Pharmaceutical Corp
NYMX
$47K 0.01%
+18,912
New +$55.1K
PHIO icon
1189
Phio Pharmaceuticals
PHIO
$12.1M
$46K 0.01%
+197
New +$50.1K
DSX icon
1190
Diana Shipping
DSX
$301M
$44K 0.01%
+44,310
New +$44.4K
DMK
1191
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$44K 0.01%
+796
New +$47.2K
ALSK
1192
DELISTED
Alaska Communications Systems
ALSK
$44K 0.01%
+21,969
New +$50.8K
VIRX
1193
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$41K 0.01%
+9,359
New +$81.8K
SID icon
1194
Companhia Siderúrgica Nacional
SID
$1.23B
$40K 0.01%
+13,500
New +$34.4K
AUD
1195
DELISTED
Audacy, Inc.
AUD
$40K 0.01%
24,861
-113,307
-82% -$170K
NH
1196
DELISTED
NantHealth, Inc
NH
$39K 0.01%
+1,113
New +$62.7K
AR icon
1197
Antero Resources
AR
$10.7B
$38K 0.01%
+13,730
New +$43.5K
OBSV
1198
DELISTED
ObsEva SA Ordinary Shares
OBSV
$38K 0.01%
+15,265
New +$43.6K
DHC
1199
Diversified Healthcare Trust
DHC
$2.14B
$36K 0.01%
+10,142
New +$39.6K
QUAD icon
1200
Quad
QUAD
$525M
$34K 0.01%
11,206
-43,732
-80% -$145K

Similar funds

GSA Capital Partners's Q3 2020 Portfolio in Review

As of Q3 2020, GSA Capital Partners held 1,485 positions worth $600M, up 234% from $179M the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.

GSA Capital Partners deployed $429M of net new capital in Q3 2020, opening 912 new positions and adding to 233 existing holdings. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 130,000 shares worth $10.9M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, down from 16% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Nebius Group N.V., an estimated $5.11M trimmed.

  • GSA Capital Partners's largest Q3 2020 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 130,000 shares worth $10.9M.
  • GSA Capital Partners added most to Michaels Stores, Inc in Q3 2020, an estimated $2.48M increase.
  • GSA Capital Partners's biggest Q3 2020 reduction was Nebius Group N.V., cutting an estimated $5.11M.
  • GSA Capital Partners fully exited T-Mobile US in Q3 2020, selling an estimated $1.77M.
  • GSA Capital Partners's ten largest holdings make up 7.8% of its $600M portfolio in Q3 2020.
  • GSA Capital Partners opened 912 new positions and closed 263 in Q3 2020.
  • GSA Capital Partners's portfolio value rose 234% quarter-over-quarter to $600M.

Based on GSA Capital Partners's 13F filing for Q3 2020, filed 6 Nov 2020.